Meningococcal B vaccine development and evaluation of efficacy

 Abstract

In this commentary we stress that serum bactericidal activity is now internationally accepted as correlate of protection for evaluating new vaccines for epidemic and endemic meningococcal B control, and that the standardization of the assay and the choice of representative strains for each of the vaccine candidates are critical.

Full Text Options
Article
Metrics
 Share
 Info
Pages
158 - 161
doi
10.4161/hv.4.2.4871
Type
Commentary
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Meningococcal B vaccine development and evaluation of efficacy